2018
DOI: 10.1016/j.biopha.2018.06.032
|View full text |Cite
|
Sign up to set email alerts
|

Protective effect of human umbilical cord mesenchymal stem cell exosomes on preserving the morphology and angiogenesis of placenta in rats with preeclampsia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
48
0
2

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 67 publications
(52 citation statements)
references
References 30 publications
2
48
0
2
Order By: Relevance
“…We assume that multiple dosing can improve the therapeutic effect and need to be further validated. Second, we found that the effect of exosome treatment on improving erection was related to the increase of VEGF content in tissues; it may because stem cells can promote tissue angiogenesis by secreting VEGF‐rich exosomes . However, due to the inclusions of exosome are very complex, there are also related researches that attribute its active ingredients to miRNAs.…”
Section: Discussionmentioning
confidence: 95%
“…We assume that multiple dosing can improve the therapeutic effect and need to be further validated. Second, we found that the effect of exosome treatment on improving erection was related to the increase of VEGF content in tissues; it may because stem cells can promote tissue angiogenesis by secreting VEGF‐rich exosomes . However, due to the inclusions of exosome are very complex, there are also related researches that attribute its active ingredients to miRNAs.…”
Section: Discussionmentioning
confidence: 95%
“…The investigators observed a protective effect of UC-MSC on trophoblast cellular functions, opening a new avenue for treating placenta-related disorders like preeclampsia (109). Interestingly, exosomes derived from UC-MSC improved the morphology and angiogenesis of the placenta in a dose-dependent manner in a rat model of preeclampsia (110). Taken together, UC-MSCs may be beneficial for preeclampsia therapy and further studies are warranted.…”
Section: Umbilical Cord Mesenchymal Stem Cells (Uc-mentioning
confidence: 94%
“…Emerging evidence suggests that neurological disorders can be successfully treated by exosome-based therapy when the auto-regenerative capacity of the central nervous system (CNS) is limited [126][127][128]. BM-MSC-derived exosomes and human umbilical cord (hUC) MSC exosomes are also effectively used for cardiac tissue neovascularization following ischemic injury [129] and for endothelial function enhancement, respectively [130,131]. Similarly, liver function is ameliorated by MSC-derived exosomes through the epithelial-mesenchymal transition (EMT) of hepatocyte and collagen production and through serum aspartate aminotransferase restoration [132][133][134][135].…”
Section: Exosomes Derived From Mesenchymal Stem/stromal Cells Of Diffmentioning
confidence: 99%